Skip to main content
. 2021 Oct 22;5(20):4185–4197. doi: 10.1182/bloodadvances.2021004939

Figure 2.

Figure 2.

Additional post-VLDRT outcomes. Cumulative incidence of DP after VLDRT for (A) the overall cohort and (B) stratified by treatment intent and of OP after VLDRT for (C) the overall cohort and (D) stratified by treatment intent with Gray’s test P value. Kaplan-Meier estimates of OS after VLDRT for (E) the overall cohort and (F) stratified by treatment intent with log-rank test P value. Shading is 95% CI.